The global Organs-on-chips market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 564.1 million by 2030 with a CAGR of 29.9% during review period.
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Global organ on chip key players include Emulate, TissUse, Mimetas, CN Bio Innovations, Valo Health, etc. Global top 5 manufacturers hold a share about 58%.
North America is the largest market, with a share about 42%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Liver-on-a-chip is the largest segment, with a share about 26%. And in terms of application, the largest application is pharmaceutical & biotechnology companies, followed by academic & research institutes.
The report includes an overview of the development of the Organs-on-chips industry chain, the market status of Pharmaceutical & Biotechnology Companies (Brain-on-a-chip, Liver-on-a-chip), Academic & Research Institutes (Brain-on-a-chip, Liver-on-a-chip), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Organs-on-chips.
Regionally, the report analyzes the Organs-on-chips markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Organs-on-chips market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Organs-on-chips market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Organs-on-chips industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Brain-on-a-chip, Liver-on-a-chip).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Organs-on-chips market.
Regional Analysis: The report involves examining the Organs-on-chips market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Organs-on-chips market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Organs-on-chips:
Company Analysis: Report covers individual Organs-on-chips players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Organs-on-chips This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Organs-on-chips. It assesses the current state, advancements, and potential future developments in Organs-on-chips areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Organs-on-chips market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Organs-on-chips market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of value.
Market segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Market segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Market segment by players, this report covers
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo, Inc.
Beijing Daxiang Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Organs-on-chips product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Organs-on-chips, with revenue, gross margin and global market share of Organs-on-chips from 2019 to 2024.
Chapter 3, the Organs-on-chips competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Organs-on-chips market forecast, by regions, type and end user, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Organs-on-chips.
Chapter 13, to describe Organs-on-chips research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Organs-on-chips
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Organs-on-chips by Type
1.3.1 Overview: Global Organs-on-chips Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Organs-on-chips Consumption Value Market Share by Type in 2023
1.3.3 Brain-on-a-chip
1.3.4 Liver-on-a-chip
1.3.5 Kidney-on-a-chip
1.3.6 Lung-on-a-chip
1.3.7 Heart-on-a-chip
1.3.8 Intestine-on-a-chip
1.3.9 Vessel-on-a-chip
1.3.10 Other Organs
1.4 Global Organs-on-chips Market by End User
1.4.1 Overview: Global Organs-on-chips Market Size by End User: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Academic & Research Institutes
1.4.4 Cosmetics Industry
1.4.5 Others
1.5 Global Organs-on-chips Market Size & Forecast
1.6 Global Organs-on-chips Market Size and Forecast by Region
1.6.1 Global Organs-on-chips Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Organs-on-chips Market Size by Region, (2019-2030)
1.6.3 North America Organs-on-chips Market Size and Prospect (2019-2030)
1.6.4 Europe Organs-on-chips Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Organs-on-chips Market Size and Prospect (2019-2030)
1.6.6 South America Organs-on-chips Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Organs-on-chips Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Emulate
2.1.1 Emulate Details
2.1.2 Emulate Major Business
2.1.3 Emulate Organs-on-chips Product and Solutions
2.1.4 Emulate Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Emulate Recent Developments and Future Plans
2.2 Mimetas
2.2.1 Mimetas Details
2.2.2 Mimetas Major Business
2.2.3 Mimetas Organs-on-chips Product and Solutions
2.2.4 Mimetas Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Mimetas Recent Developments and Future Plans
2.3 TissUse
2.3.1 TissUse Details
2.3.2 TissUse Major Business
2.3.3 TissUse Organs-on-chips Product and Solutions
2.3.4 TissUse Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 TissUse Recent Developments and Future Plans
2.4 Valo Health
2.4.1 Valo Health Details
2.4.2 Valo Health Major Business
2.4.3 Valo Health Organs-on-chips Product and Solutions
2.4.4 Valo Health Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Valo Health Recent Developments and Future Plans
2.5 CN Bio Innovations
2.5.1 CN Bio Innovations Details
2.5.2 CN Bio Innovations Major Business
2.5.3 CN Bio Innovations Organs-on-chips Product and Solutions
2.5.4 CN Bio Innovations Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CN Bio Innovations Recent Developments and Future Plans
2.6 Hesperos
2.6.1 Hesperos Details
2.6.2 Hesperos Major Business
2.6.3 Hesperos Organs-on-chips Product and Solutions
2.6.4 Hesperos Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hesperos Recent Developments and Future Plans
2.7 Draper Laboratory
2.7.1 Draper Laboratory Details
2.7.2 Draper Laboratory Major Business
2.7.3 Draper Laboratory Organs-on-chips Product and Solutions
2.7.4 Draper Laboratory Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Draper Laboratory Recent Developments and Future Plans
2.8 Nortis
2.8.1 Nortis Details
2.8.2 Nortis Major Business
2.8.3 Nortis Organs-on-chips Product and Solutions
2.8.4 Nortis Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Nortis Recent Developments and Future Plans
2.9 Micronit Microtechnologies B.V.
2.9.1 Micronit Microtechnologies B.V. Details
2.9.2 Micronit Microtechnologies B.V. Major Business
2.9.3 Micronit Microtechnologies B.V. Organs-on-chips Product and Solutions
2.9.4 Micronit Microtechnologies B.V. Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Micronit Microtechnologies B.V. Recent Developments and Future Plans
2.10 Kirkstall
2.10.1 Kirkstall Details
2.10.2 Kirkstall Major Business
2.10.3 Kirkstall Organs-on-chips Product and Solutions
2.10.4 Kirkstall Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Kirkstall Recent Developments and Future Plans
2.11 Cherry Biotech SAS
2.11.1 Cherry Biotech SAS Details
2.11.2 Cherry Biotech SAS Major Business
2.11.3 Cherry Biotech SAS Organs-on-chips Product and Solutions
2.11.4 Cherry Biotech SAS Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cherry Biotech SAS Recent Developments and Future Plans
2.12 Else Kooi Laboratory
2.12.1 Else Kooi Laboratory Details
2.12.2 Else Kooi Laboratory Major Business
2.12.3 Else Kooi Laboratory Organs-on-chips Product and Solutions
2.12.4 Else Kooi Laboratory Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Else Kooi Laboratory Recent Developments and Future Plans
2.13 Altis Biosystems
2.13.1 Altis Biosystems Details
2.13.2 Altis Biosystems Major Business
2.13.3 Altis Biosystems Organs-on-chips Product and Solutions
2.13.4 Altis Biosystems Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Altis Biosystems Recent Developments and Future Plans
2.14 Bi/ond
2.14.1 Bi/ond Details
2.14.2 Bi/ond Major Business
2.14.3 Bi/ond Organs-on-chips Product and Solutions
2.14.4 Bi/ond Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Bi/ond Recent Developments and Future Plans
2.15 Netri
2.15.1 Netri Details
2.15.2 Netri Major Business
2.15.3 Netri Organs-on-chips Product and Solutions
2.15.4 Netri Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Netri Recent Developments and Future Plans
2.16 Xona Microfluidics
2.16.1 Xona Microfluidics Details
2.16.2 Xona Microfluidics Major Business
2.16.3 Xona Microfluidics Organs-on-chips Product and Solutions
2.16.4 Xona Microfluidics Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Xona Microfluidics Recent Developments and Future Plans
2.17 SynVivo, Inc.
2.17.1 SynVivo, Inc. Details
2.17.2 SynVivo, Inc. Major Business
2.17.3 SynVivo, Inc. Organs-on-chips Product and Solutions
2.17.4 SynVivo, Inc. Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 SynVivo, Inc. Recent Developments and Future Plans
2.18 Beijing Daxiang Biotech
2.18.1 Beijing Daxiang Biotech Details
2.18.2 Beijing Daxiang Biotech Major Business
2.18.3 Beijing Daxiang Biotech Organs-on-chips Product and Solutions
2.18.4 Beijing Daxiang Biotech Organs-on-chips Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Beijing Daxiang Biotech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Organs-on-chips Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Organs-on-chips by Company Revenue
3.2.2 Top 3 Organs-on-chips Players Market Share in 2023
3.2.3 Top 6 Organs-on-chips Players Market Share in 2023
3.3 Organs-on-chips Market: Overall Company Footprint Analysis
3.3.1 Organs-on-chips Market: Region Footprint
3.3.2 Organs-on-chips Market: Company Product Type Footprint
3.3.3 Organs-on-chips Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Organs-on-chips Consumption Value and Market Share by Type (2019-2024)
4.2 Global Organs-on-chips Market Forecast by Type (2025-2030)
5 Market Size Segment by End User
5.1 Global Organs-on-chips Consumption Value Market Share by End User (2019-2024)
5.2 Global Organs-on-chips Market Forecast by End User (2025-2030)
6 North America
6.1 North America Organs-on-chips Consumption Value by Type (2019-2030)
6.2 North America Organs-on-chips Consumption Value by End User (2019-2030)
6.3 North America Organs-on-chips Market Size by Country
6.3.1 North America Organs-on-chips Consumption Value by Country (2019-2030)
6.3.2 United States Organs-on-chips Market Size and Forecast (2019-2030)
6.3.3 Canada Organs-on-chips Market Size and Forecast (2019-2030)
6.3.4 Mexico Organs-on-chips Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Organs-on-chips Consumption Value by Type (2019-2030)
7.2 Europe Organs-on-chips Consumption Value by End User (2019-2030)
7.3 Europe Organs-on-chips Market Size by Country
7.3.1 Europe Organs-on-chips Consumption Value by Country (2019-2030)
7.3.2 Germany Organs-on-chips Market Size and Forecast (2019-2030)
7.3.3 France Organs-on-chips Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Organs-on-chips Market Size and Forecast (2019-2030)
7.3.5 Russia Organs-on-chips Market Size and Forecast (2019-2030)
7.3.6 Italy Organs-on-chips Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Organs-on-chips Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Organs-on-chips Consumption Value by End User (2019-2030)
8.3 Asia-Pacific Organs-on-chips Market Size by Region
8.3.1 Asia-Pacific Organs-on-chips Consumption Value by Region (2019-2030)
8.3.2 China Organs-on-chips Market Size and Forecast (2019-2030)
8.3.3 Japan Organs-on-chips Market Size and Forecast (2019-2030)
8.3.4 South Korea Organs-on-chips Market Size and Forecast (2019-2030)
8.3.5 India Organs-on-chips Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Organs-on-chips Market Size and Forecast (2019-2030)
8.3.7 Australia Organs-on-chips Market Size and Forecast (2019-2030)
9 South America
9.1 South America Organs-on-chips Consumption Value by Type (2019-2030)
9.2 South America Organs-on-chips Consumption Value by End User (2019-2030)
9.3 South America Organs-on-chips Market Size by Country
9.3.1 South America Organs-on-chips Consumption Value by Country (2019-2030)
9.3.2 Brazil Organs-on-chips Market Size and Forecast (2019-2030)
9.3.3 Argentina Organs-on-chips Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Organs-on-chips Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Organs-on-chips Consumption Value by End User (2019-2030)
10.3 Middle East & Africa Organs-on-chips Market Size by Country
10.3.1 Middle East & Africa Organs-on-chips Consumption Value by Country (2019-2030)
10.3.2 Turkey Organs-on-chips Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Organs-on-chips Market Size and Forecast (2019-2030)
10.3.4 UAE Organs-on-chips Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Organs-on-chips Market Drivers
11.2 Organs-on-chips Market Restraints
11.3 Organs-on-chips Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Organs-on-chips Industry Chain
12.2 Organs-on-chips Upstream Analysis
12.3 Organs-on-chips Midstream Analysis
12.4 Organs-on-chips Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo, Inc.
Beijing Daxiang Biotech
听
听
*If Applicable.
